Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | CETP | P11597 | 1/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2307042 | 0.94 | CSNK1E (0.53) | CYP1A2CYP2C9CYP2C19HTR1ACSNK1E | |
| SCHEMBL9279770 | 0.93 | CSNK1E (0.55) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| SCHEMBL5806424 | 0.93 | CSNK1E (0.55) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| SCHEMBL10451596 | 0.93 | CSNK1E (0.55) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| SCHEMBL19511634 | 0.92 | TRPA1 (0.49) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| Hydrochloric Acid SCHEMBL9343514 | 0.91 | CSNK1E (0.54) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| Ammonia Solution, Strong SCHEMBL4443336 | 0.91 | CSNK1E (0.54) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| Water SCHEMBL9248814 | 0.91 | CSNK1E (0.54) | HTR1ACSNK1ECNR2SIGMAR1TRPA1 | |
| SCHEMBL6671960 | 0.89 | TRPA1 (0.58) | CSNK1ESIGMAR1TRPA1 | |
| SCHEMBL14402642 | 0.88 | TSHR (0.49) | TSHRSIGMAR1DPP4MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3239261-B1 | METHOD FOR PRODUCING AN ADHESIVE COMPOSITION AND A LAMINATE | TOYO INK SC HOLDINGS CO LTD (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| CN-107406744-B | Method for producing adhesive composition and method for producing laminate | 东洋油墨SC控股株式会社 | 2020-06-23 | — | — | CN | disclosed |
| US-9951259-B2 | Adhesive composition and laminate | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20170355891-A1 | ADHESIVE COMPOSITION AND LAMINATE | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2017-12-14 | — | — | US | disclosed |
| EP-3239261-A1 | ADHESIVE COMPOSITION AND LAMINATE | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2017-11-01 | — | — | EP | disclosed |
| EP-0974572-B1 | NOVEL PROCESS FOR PRODUCING ALCOHOLS | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-11-26 | — | — | EP | disclosed |
| US-6271425-B1 | REACTING AN ORGANIC HALIDE WITH OXYGEN MOLECULES IN THE PRESENCE OF AN ORGANOTIN COMPOUND AND A REDUCING AGENT AND OPTIONALLY A FREE-RADICAL INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-07 | — | — | US | disclosed |
| EP-0974572-A1 | NOVEL PROCESS FOR PRODUCING ALCOHOLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HPD, TALDO1, OGG1 | CYP1A2 537/4885CYP2C9 241/4885CYP2C19 970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.